Moderna reports positive results in head and neck cancer
PARIS - Moderna shares rose 8 per cent to a three-month high after the company's individualized cancer vaccine developed with ...
Read morePARIS - Moderna shares rose 8 per cent to a three-month high after the company's individualized cancer vaccine developed with ...
Read moreWASHINGTON - The US health regulator has approved Japan-based Daiichi Sankyo Co's therapy for newly diagnosed patients with an aggressive ...
Read moreWould you like to receive notifications on our latest news ?
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.